SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?


To: GREG FINLEY who wrote (452)6/21/2000 11:48:00 AM
From: geewiz  Read Replies (1) | Respond to of 534
 
Greg,

Let's state the case in less robust terms;

>> If O'Shea can not deliver a good sustaining revenue stream in the next several months Elan will buy the 56% of the shares they do not own and get to name the price!

Just give it some thought Greg; you may say;
"Elan never wanted to acquire the delivery platform"

but at a bargin price - how could they pass it up??

I hope I am wrong!

best, art